Latest Headlines

  1. PolyPeptide Strengthens Global Peptide Production With Modular Facility Design Approach 9/24/2025

    PolyPeptide Group AG (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful delivery and installation of pre-built modules at its Malmö, Sweden facility. This marks a key milestone in the company’s modular expansion project at the site, which aims to double its solid-phase peptide synthesis (SPPS) capacity.

  2. $60M Series B Financing Propels Avenzo Therapeutics Forward 9/24/2025

    Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the closing of a $60 million Series B financing. This funding, which follows Avenzo’s $386 million Series A/A-1 financing announced in November 2024, brings the total capital raised to $446 million. The proceeds will be used to support the advancement of Avenzo’s pipeline of potential best-in-class oncology drug candidates.

  3. Eli Lilly's New Texas Facility To Boost Small Molecule Production 9/23/2025

    The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines.

  4. Groninger Acquires Isolator And Cleanroom OEM Reinraumtechnik Ulm 9/18/2025

    With this strategic move, the family-owned company headquartered in Crailsheim not only expands its technological portfolio but also strengthens its expertise in a field that is crucial to the pharmaceutical industry: cleanroom and isolator technology.

  5. GSK Commits $30B To U.S. R&D And Drug Manufacturing Expansion 9/17/2025

    GSK plc (LSE/NYSE: GSK) today announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years.

  6. Eli Lilly Announces Plans To Build New $5 Billion Drug Manufacturing Facility In Virginia 9/17/2025

    Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. The new site will be the company's first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly's emerging bioconjugate platform and monoclonal antibody portfolio.

  7. CAI Appoints Jamie Robertson As Vice President Of Mission Critical To Drive Innovation And Operational Excellence Across Global Infrastructure Projects 9/14/2025

    CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the appointment of Jamie Robertson as Vice President of Mission Critical.

  8. Körber To Exhibit Aseptic Processing, Packaging, Inspection And MES Software Technologies At Pack Expo 2025 9/11/2025

    Körber, a major international technology group, invites media to visit its booth at Pack Expo 2025 in Las Vegas. This is a unique opportunity to discover how Körber is transforming entrepreneurial thinking into tangible customer success and shaping technological change.

  9. Assets Of Sutro Biopharma To Be Auctioned – December 2025 9/11/2025

    Late-model lab R&D and manufacturing equipment surplus to future needs of Sutro biopharma: spray dryer, chromatography systems, Westfalia separators, HPLCs & more.

  10. Upperton Wins Pharma Contract Services Company Of The Year At The Pharma Industry Awards UK 2025 9/11/2025

    Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks a second year of success at the Pharma Industry Awards, with a win in 2024 for Large Pharma Project of the Year.